Malta - engelska - Medicines Authority

rontis hellas medical and pharmaceutical products s.a. 38, sorou str., athens, maroussi, 15125, greece - aprepitant - hard capsule - aprepitant 80 mg - antiemetics and antinauseants

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - aprepitant 80mg - capsule - 80 mg - active: aprepitant 80mg excipient: gelatin hyprolose microcrystalline cellulose sodium laurilsulfate sucrose - emend, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: · moderately emetogenic cancer chemotherapy. · highly emetogenic cancer chemotherapy.

Australien - engelska - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - fosaprepitant dimeglumine, quantity: 257.6 mg (equivalent: fosaprepitant, qty 150 mg) - injection, powder for - excipient ingredients: disodium edetate; sodium hydroxide; hydrochloric acid; polysorbate 80; lactose - emend iv, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: - highly emetogenic cancer chemotherapy (see dosage and administration); - moderately emetogenic cancer chemotherapy (see dosage and administration).

Belgien - engelska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pharmathen s.a. - aprepitant 80 mg - capsule, hard - 80 mg - aprepitant 80 mg - aprepitant

Australien - engelska - Department of Health (Therapeutic Goods Administration)

reach pharmaceuticals pty ltd - fosaprepitant dimeglumine, quantity: 245.3 mg (equivalent: fosaprepitant, qty 150 mg) - injection, powder for - excipient ingredients: lactose; polysorbate 80; hydrochloric acid; sodium hydroxide; disodium edetate - fosaprepitant msn, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of:,? highly emetogenic cancer chemotherapy (see section 4.2 dose and method of administration),? moderately emetogenic cancer chemotherapy (see section 4.2 dose and method of administration).

USA - engelska - NLM (National Library of Medicine)

physicians total care, inc. - aprepitant (unii: 1nf15yr6uy) (aprepitant - unii:1nf15yr6uy) - aprepitant 80 mg - emend, in combination with other antiemetic agents, is indicated for the: - prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (hec) including high-dose cisplatin - prevention of nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (mec) [see dosage and administration (2.1)] . emend is indicated for the prevention of postoperative nausea and vomiting [see dosage and administration (2.2)] . emend has not been studied for the treatment of established nausea and vomiting. chronic continuous administration is not recommended [see warnings and precautions (5.5)]. emend is contraindicated in patients who are hypersensitive to any component of the product. emend is a dose-dependent inhibitor of cytochrome p450 isoenzyme 3a4 (cyp3a4). emend should not be used concurrently with pimozide, terfenadine, astemizole, or cisapride. inhibition of cyp3a4 by aprepitant could result in elev

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

merck sharp & dohme (new zealand) limited - aprepitant 80mg; aprepitant 125mg - combination capsule - 80/125mg - active: aprepitant 80mg excipient: gelatin hyprolose microcrystalline cellulose sodium laurilsulfate sucrose active: aprepitant 125mg excipient: gelatin hyprolose microcrystalline cellulose sodium laurilsulfate sucrose - emend, in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: · moderately emetogenic cancer chemotherapy. · highly emetogenic cancer chemotherapy.

Singapore - engelska - HSA (Health Sciences Authority)

msd pharma (singapore) pte. ltd. - aprepitant - capsule - 80 mg - aprepitant 80 mg

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

alchemy health limited - aprepitant 80mg; aprepitant 125mg - combination capsule - active: aprepitant 80mg excipient: gelatin hypromellose microcrystalline cellulose opacode black s-1-17823 poloxamer 407 purified water sodium laurilsulfate sucrose titanium dioxide active: aprepitant 125mg excipient: gelatin hypromellose iron oxide red microcrystalline cellulose opacode black s-1-17823 poloxamer 407 purified water sodium laurilsulfate sucrose titanium dioxide - in combination with other antiemetic agents, aprepitant is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: - highly emetogenic cancer chemotherapy - moderately emetogenic cancer chemotherapy

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

alchemy health limited - aprepitant 80mg - capsule - 80 mg - active: aprepitant 80mg excipient: gelatin hypromellose microcrystalline cellulose opacode black s-1-17823 poloxamer 407 purified water sodium laurilsulfate sucrose titanium dioxide - in combination with other antiemetic agents, aprepitant is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of: - highly emetogenic cancer chemotherapy - moderately emetogenic cancer chemotherapy